Previous Close | 0.8994 |
Open | 0.9100 |
Bid | 0.8352 x 1100 |
Ask | 0.8680 x 600 |
Day's Range | 0.8503 - 0.9100 |
52 Week Range | 0.5300 - 1.5400 |
Volume | |
Avg. Volume | 1,587,432 |
Market Cap | 153.212M |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Nov 09, 2012 |
1y Target Est | N/A |
Explore key financial outcomes, clinical trial updates, and strategic plans from Vaxart's latest earnings call.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Vaxart fair value estimate is US$0.90 With US$1.08 share...